Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Tmp Q4 2025 Earnings Tompkins Financial Corporation Posts Huge Eps Beat 20260403 1 Is Amylyx Amlx Stock A Buy Now Price At 14.95 Up 4.18 20260402 Will Palladyne Pdynw Stock Go Higher Price At 0.08 Up 19.70 20260409 Will Novabridge Nbp Stock Miss Expectations Price At 2.44 Up 0.62 20260406 Is Quaker Houghton Kwr Stock Moving Sideways Price At 127.42 Down 0.96 20260409 How much upside is really left in Sharplink SBET Trend Weakens 20260507 ONON On Holding AG tops Q4 2025 EPS expectations by a wide margin sending shares up over four percent Why are smart money investors paying attention to Sanmina Corporation SANM Extends Gains 20260510 AIV Aimco shares fall 162 after Q3 earnings miss estimates by 44 despite modest revenue growth AIRG Airgain shares gain over two percent even as Q4 2025 losses vastly exceed analyst expectations Vanguard Energy Index Fund ETF Shares VDE Investment Case and Comparative Performance Analysis for 2026 CAEP CantorEquity reports quarterly earnings with key metrics pending market monitors for additional disclosure Columbia Bank COLB Stock Fair Value Assessment Q4 2025 Better Than Expected Ferrovial SE FER Stock Is It Undervalued Risk Aversion 20260420 Why MYR Group MYRG looks attractive at current levels Sinks 20260508 Zebra ZBRA Stock Fundamentals Zebra Posts 2 EPS Miss Trailing Street Estimates What Matinas MTNB does that makes it resilient Institutional Selling 20260508 CVV CVD Equipment shares rise 235 percent after reporting its Q4 2025 quarterly earnings results Why New Era NUAI is still under the radar Volatility Increases 20260508 Accel Ent ACEL Q1 2026 Earnings Surprise EPS 031 Up Significant Royal Observatory Issues Caution Instant AI Answers May Trivialise Human Intelligence EU Negotiators Reach Provisional Deal on Safeguard Clauses for EUUS Trade Agreement Michigan Man Sentenced to 30 Years After Fatal Wedding Night Incident Involving Best Friend Tech Sits Out the US IPO Rush as Biotech and Healthcare Stocks Flock to Go Public X4 Pharmaceuticals XFOR Q1 2026 Earnings Why the Beat Matters CALM Chain Files for Nasdaq IPO 3 Million Shares Proposed in Public Offering Edible Oil Inflation Adds to Economic Woes as Rupee Weakens PM Modi Urges Consumption Cut Greeces Q1 2026 Budget Surplus Hits 5175bn More Than Doubling Official Target FuelCell Energy Drags Hydrogen Sector Lower Market Sentiment Sours ARKO Corp ARKO Gains 33 as Shares Approach Key Resistance at 789 Comstock Res CRK Stock Analysis 535 Loss Key Levels 20260520 Pet Supplies Retailer Files for Chapter 11 Bankruptcy Amid Industry Challenges Berkshire Hathaway Increases Alphabet Stake by 224 and Takes 26 Billion Position in Delta Air Lines Survey Reveals Americans Cut Spending Amid Stock Market Highs Atmos Energy Stock Outlook Wall Street Sentiment Divided Thor Industries THO Q1 2026 Earnings Massive Earnings Beat Surprises the Market AIFU Q3 2023 Earnings Profitability Surfaces Amidst Uncertain Revenue Disclosure HTO Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher TScan Therapeutics Q1 2026 Earnings Narrowing Loss Despite EPS Miss Stock Gains on Pipeline Progress CSRS Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges Intapp Inc INTA Slides 279 as Bearish Pressure Intensifies Warby Parker Eyes Resistance at 2609 After 143 Gain PIMCO Access Income Fund PAXS Shows Resilience with 107 Gain Tests Key Resistance Bread BFH Stock Forecast 2026 Buy Now Slight Rise 20260420 ODD ODDITY notches a substantial Q4 2025 EPS beat as shares rise modestly on positive investor reaction Is ORIX IX stock worth adding to a portfolio Smart Money Exits 20260420 Moderna Inc MRNA Unveils Positive Phase 12 mRNA Cancer Therapy Data at 2026 AACR Earns FDA Fast Track Designation WFC Wells posts slight Q1 2026 EPS and revenue growth but shares drop 119 percent in todays trading Market Wrap SP 500 edges down as major US indices end mixed PBMWW Psyence highlights clinical trial progress as core strategic priority in its latest quarterly earnings release